AV
Arcus Ventures
Private EquityActiveFounded in 2007, Arcus Ventures invests in oncology-focused companies with advanced biopharmaceuticals and is a private equity company.
17
Investments
4
Exits
—
AUM
23.5%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Arcus Ventures.
Investment Thesis & Strategy
Arcus Ventures, a private equity firm, invests in various stages of oncology-focused biotech companies with advanced biopharmaceuticals, leveraging its expertise in the biotech sector.
Investment Activity
Deals per year over the last 9 years
1
20080
20090
20100
20110
20121
20130
20140
20151
2016Portfolio Companies
Selected investments from their portfolio of 17 companies
A
Astellas Pharma
Biotech · Growth, 2016
I
Ignyta
Biotech · Series B, 2013
O
OncoMed Pharmaceuticals
Biotech · Series A, 2008
Frequently Asked Questions
Arcus Ventures focuses on Series B, Series C+ stage investments.